Cargando…
Polymorphism of Methylenetetrahydrofolate Reductase (MTHFR) gene and risk of Head and Neck Squamous Cell Carcinoma
ABSTRACT: Methylenetetrahydrofolate reductase gene (MTHFR) C677T polymorphism may be a risk factor for head and neck squamous cell carcinoma due to changes in folate levels that can induce disorders in the methylation pathway, which results in carcinogenesis. AIM: To evaluate MTHFR C677T polymorphis...
Autores principales: | Rodrigues, Juliana Olsen, Galbiatti, Ana Lívia Silva, Ruiz, Mariangela Torreglosa, Raposo, Luiz Sergio, Maniglia, José Victor, Pavarino-Bertelli, Érika Cristina, Goloni-Bertollo, Eny Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443740/ https://www.ncbi.nlm.nih.gov/pubmed/21180947 http://dx.doi.org/10.1590/S1808-86942010000600017 |
Ejemplares similares
-
Head and neck cancer: genetic polymorphisms and folate metabolism
por: Galbiatti, Ana Lívia Silva, et al.
Publicado: (2015) -
The association between CBS 844ins68 polymorphism and head and neck squamous cell carcinoma risk – a case-control analysis
por: Galbiatti, Ana L.S, et al.
Publicado: (2010) -
Analysis of the TAX1BP1 gene in head and neck cancer patients
por: Ruiz, Mariangela Torreglosa, et al.
Publicado: (2015) -
Epidemiologic evaluation of head and neck patients in a university hospital of Northwestern São Paulo State
por: de Melo Alvarenga, Larissa, et al.
Publicado: (2015) -
GSTT1 and GSTM1 polymorphism in cigarette smokers with head and neck squamous cell carcinoma
por: Biselli, Joice Matos, et al.
Publicado: (2015)